Kewei Fu

53 papers receiving 3.2k citations

Kewei Fu's Hit Papers

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. 1998 · 1.9k citations
1.9k0+9+18Years since publication5001k1.5k

Peers

Kewei Fu
Comparison fields: 5 of 88
  • Otorhinolaryngology 1.9k
  • Surfaces, Coatings and Films 313
  • Radiation 162
  • Pulmonary and Respiratory Medicine 348
  • Cancer Research 107
Replace Takehiro Inoue with:
Takehiro Inoue Japan
C. Chao United States
Ding‐Jen Lee United States
Michela Buglione Italy
Ngan‐Ming Tsang Taiwan
Werner Dobrowsky Austria
Johnny Kao United States
Harold E. Kim United States
Bernard Luboinski France
Luigi Tomio Italy
Kewei Fu relative to Takehiro Inoue Japan Takehiro Inoue's profile →
Citations per field
00.5×50×104.3×
Takehiro Inoue · 1×
Citations per year

Countries citing papers authored by Kewei Fu

Since Specialization
Citations

This map shows the geographic impact of Kewei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Fu more than expected).

Fields of papers citing papers by Kewei Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Fu. The network helps show where Kewei Fu may publish in the future.

Co-authors

The 25 scholars most cited alongside Kewei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kewei Fu Line = papers co-authored together Kewei Fu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
Hit paper breakdown →
19981858
2 1998176
3 1997141
4 2013136
5
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
199991
6 199183
7 198778
8 201374
9 199859
10 201355
11 201254
12 197953
13 200235
14 200435
15 201534
16 200333
17 198128
18 197426
19 200525
20 200424

About Kewei Fu

Kewei Fu is a scholar working on Otorhinolaryngology, Surfaces, Coatings and Films, Radiation, Pulmonary and Respiratory Medicine and Cancer Research, having authored 55 papers that have together received 3.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (27 papers), Surface Modification and Superhydrophobicity (5 papers), Radiation Therapy and Dosimetry (5 papers), Advanced Radiotherapy Techniques (5 papers), Effects of Radiation Exposure (4 papers), Breast Cancer Treatment Studies (4 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (1.9k citations), Surfaces, Coatings and Films (313 citations), Radiation (162 citations), Pulmonary and Respiratory Medicine (348 citations) and Cancer Research (107 citations). Kewei Fu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jay Scott Cooper, Muhyi Al‐Sarraf, John F. Ensley, Wael Sakr, A A Forastiere, T. Vuong, Michael Leo LeBlanc, George L. Adams, Kening Sun and Zhongjun Cheng. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, ACS Applied Materials & Interfaces, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact